<table id="ID183" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 5. Established and Other Potentially Significant Drug Interactions</caption>
<col width="27%"></col>
<col width="29%"></col>
<col width="44%"></col>
<tfoot>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">↓ = Decreased (induces lamotrigine glucuronidation).<br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">↑ = Increased (inhibits lamotrigine glucuronidation).<br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">? = Conflicting data.<br/>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">
<content stylecode="bold">Effect </content>
<content stylecode="bold">on </content>
<content stylecode="bold">Concentration </content>
<content stylecode="bold">of </content>
<content stylecode="bold">Lamotrigine </content>
<content stylecode="bold">or </content>
<content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Clinical </content>
<content stylecode="bold">Comment</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Estrogen-containing oral<br/>contraceptive<br/>preparations containing<br/>30 mcg ethinylestradiol<br/>and 150 mcg<br/>levonorgestrel<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
<br/>↓ levonorgestrel<br/>
<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine concentrations approximately 50%.<br/>Decrease in levonorgestrel component by 19%.<br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Carbamazepine and<br/>carbamazepine epoxide<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
<br/>
<br/>? carbamazepine epoxide<br/>
<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Addition of carbamazepine decreases lamotrigine concentration approximately<br/>40%.<br/>May increase carbamazepine epoxide levels.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Lopinavir/ritonavir <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine <br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine concentration approximately 50%. <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Atazanavir/ritonavir <br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine <br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine AUC approximately 32%. <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenobarbital/Primidone<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine concentration approximately 40%.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenytoin<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine concentration approximately 40%.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Rifampin<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine AUC approximately 40%.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Valproate<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑ lamotrigine<br/>
<br/>? valproate<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Increased lamotrigine concentrations slightly more than 2-fold.<br/>There are conflicting study results regarding effect of lamotrigine on valproate concentrations: 1) a mean 25% decrease in valproate concentrations in healthy volunteers, 2) no change in valproate concentrations in controlled clinical trials in patients with epilepsy.<br/>
</td>
</tr>
</tbody>
</table>